MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dinos, G. P.
Right arrow Articles by Kalpaxis, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dinos, G. P.
Right arrow Articles by Kalpaxis, D. L.

Vol. 63, Issue 3, 617-623, March 2003

Erythromycin, Roxithromycin, and Clarithromycin: Use of Slow-Binding Kinetics to Compare Their in Vitro Interaction with a Bacterial Ribosomal Complex Active in Peptide Bond Formation

George P. Dinos, Sean R. Connell, Knud H. Nierhaus, and Dimitrios L. Kalpaxis

Laboratory of Biochemistry, School of Medicine, University of Patras, Patras, Greece (G.P.D., D.L.K.); Max-Planck-Institut für Molekulare Genetik, AG Ribosomen, Berlin, Germany (S.R.C., K.H.N.); and Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada (S.R.C.)

In a cell-free system derived from Escherichia coli, it is shown that clarithromycin and roxithromycin, like their parent compound erythromycin, do not inhibit the puromycin reaction (i.e., the peptide bond formation between puromycin and AcPhe-tRNA bound at the P-site of 70S ribosomes programmed with heteropolymeric mRNA). Nevertheless, all three antibiotics compete for binding on the ribosome with tylosin, a 16-membered ring macrolide that behaves as a slow-binding, slowly reversible inhibitor of peptidyltransferase. The mutually exclusive binding of these macrolides to ribosomes is also corroborated by the fact that they protect overlapping sites in domain V of 23S rRNA from chemical modification by dimethyl sulfate. From this competition effect, detailed kinetic analysis revealed that roxithromycin or clarithromycin (A), like erythromycin, reacts rapidly with AcPhe-tRNA·MF-mRNA·70S ribosomal complex (C) to form the encounter complex CA which is then slowly isomerized to a more tight complex, termed C*A. The value of the overall dissociation constant, K<UP><SUB>A</SUB><SUP>*</SUP></UP>, encompassing both steps of macrolide interaction with complex C, is 36 nM for erythromycin, 20 nM for roxithromycin, and 8 nM for clarithromycin. Because the off-rate constant of C*A complex does not significantly differ among the three macrolides, the superiority of clarithromycin as an inhibitor of translation in E. coli cells and many Gram-positive bacteria may be correlated with its greater rate of association with ribosomes.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. Dreier, E. Amantea, L. Kellenberger, and M. G. P. Page
Activity of the Novel Macrolide BAL19403 against Ribosomes from Erythromycin-Resistant Propionibacterium acnes
Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4361 - 4365.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Karahalios, D. L. Kalpaxis, H. Fu, L. Katz, D. N. Wilson, and G. P. Dinos
On the Mechanism of Action of 9-O-Arylalkyloxime Derivatives of 6-O-Mycaminosyltylonolide, a New Class of 16-Membered Macrolide Antibiotics
Mol. Pharmacol., October 1, 2006; 70(4): 1271 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Yan, E. Hunt, J. Berge, E. May, R. A. Copeland, and R. R. Gontarek
Fluorescence Polarization Method To Characterize Macrolide-Ribosome Interactions
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3367 - 3372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lovmar, T. Tenson, and M. Ehrenberg
Kinetics of Macrolide Action: THE JOSAMYCIN AND ERYTHROMYCIN CASES
J. Biol. Chem., December 17, 2004; 279(51): 53506 - 53515.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics